Tempus
AI-powered precision medicine platform for oncology and clinical insights
Enterprise·All audiences·Powered by Proprietary·API available
Key strengths
One of the world's largest clinico-genomic databasesAI-driven oncology insights and companion diagnosticsReal-time data integration across genomics, imaging, and EHRSupports physicians with treatment decision supportStrong research & biopharma partnership network
Enterprise pricing
Chicago, USA
Founded 2015
No ratings yet
- Biopharma Cohort Discovery: Pharmaceutical researchers query Tempus's de-identified database to identify patient cohorts with specific genomic profiles for drug development and companion diagnostic validation.
- Biomarker Analysis at Scale: Data scientists access structured variant, expression, and clinical outcome data via API to train predictive models for treatment response and disease progression.
- FHIR-Based EHR Integration: Health IT teams integrate Tempus genomic reports and clinical trial matches directly into Epic or Cerner workflows using SMART on FHIR applications.
- AI Model Benchmarking: Research teams use Tempus's multimodal datasets (genomics + imaging + clinical) to benchmark and fine-tune their own oncology AI models.
- Real-World Evidence Generation: Outcomes researchers leverage Tempus's longitudinal real-world data to support regulatory submissions, payer negotiations, and health economics studies.
- Automated Lab Ordering & Result Routing: Developers build integrations using Tempus APIs to automate test ordering, status tracking, and result delivery within clinical information systems.